Status:
UNKNOWN
SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein Positivity
Lead Sponsor:
Trakya University
Conditions:
Basal Cell Carcinoma
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Non-melanocytic skin cancers are the most common type of cancer worldwide. In the development of this cancer type, environmental factors such as UV and smoking are emphasized. Epigenetics are genetic...
Eligibility Criteria
Inclusion
- People diagnosed clinically and dermoscopically with non-melanocytic skin cancer
- No other cancer history
- over 18 years old
- Newly diagnosed
- No systemic or topical therapy
Exclusion
- Under 18 and pregnant
- People with non-melanocytic skin cancer who are in the process of follow-up and treatment
- has another cancer history
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04759261
Start Date
December 1 2020
End Date
December 31 2022
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Trakya University
Edirne, Turkey (Türkiye), 22000